Viewing nowCombinationEmpogaduo Tablets 5/850 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.

MFDS item code 202201364 · Approved 2022.04.04 · Insurance code 651206210
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is an adjunct to blood sugar control using Empagliflozin and Metformin, primarily used alongside dietary and exercise regimens to help manage blood sugar levels in adult patients with type 2 diabetes. It is particularly used in adult patients with type 2 diabetes who have insufficient blood sugar control and have cardiovascular disease, and the risk of cardiovascular events for these patients should be consulted based on specialized clinical trial information. This medication improves blood sugar control and aids in the health management of patients with type 2 diabetes.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined according to each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients taking this medicine who do not achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take twice the dose at one time; if this occurs, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual single-ingredient products of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered as this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Cautious Administration, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication is an antidiabetic agent that helps control blood sugar, with the two components working together to lower blood sugar levels. This medication can cause rare side effects such as severe lactic acidosis, and should not be used in patients with impaired kidney function or conditions such as acute infections, dehydration, or heart disease. When taken with insulin or sulfonylureas, caution should be exercised as hypoglycemia may occur. Patients with moderate to severe renal impairment, those in acute renal situations, patients with type 1 diabetes, pregnant or breastfeeding women, and those with heart failure should not take this medication. If undergoing surgery or tests involving iodinated contrast agents, the medication should be discontinued for a certain period prior, and can only be resumed after kidney function is confirmed to be normal. Elderly patients or those with slight renal impairment should regularly undergo kidney function testing while adjusting the dosage of this medication. During the course of this medication, care should be taken to avoid dehydration or fluid loss, and if gastrointestinal disturbances such as vomiting or diarrhea occur, the doctor should be consulted. Furthermore, this medication may increase the risk of genital and urinary tract infections, thus treatment should be sought immediately if any relevant symptoms arise. Vitamin B12 levels may decrease, so it is advisable to check blood tests if there are signs of anemia or neurological symptoms. Women who are pregnant or may become pregnant should not take this medication, and it is also best avoided during breastfeeding. In the event of overdose, serious side effects such as lactic acidosis may occur, so adherence to the prescribed dosage is critical, and if side effects are suspected, immediate medical attention should be sought. This medication may interact with other drugs, so if other medications are being taken, it is essential to inform a doctor or pharmacist. Finally, this medication should be stored out of reach of children and kept in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a sealed container. Additionally, it is best stored at room temperature between 1 to 30 degrees Celsius. This will help maintain the effectiveness of the medication for a longer period.
White, oval, biconvex film-coated tablet with a yellowish tint
For domestic use - 10 tablets/box [(10 tablets/PTP x 1)], for domestic use - 60 tablets/box [(10 tablets/PTP x 6)], for domestic use - 30 tablets/bottle, for domestic use - 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.